IE
AVBP icon

Israel Englander’s ArriVent BioPharma AVBP Stock Holding History

Israel Englander’s Portfolio AVBP Stock Details AVBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.2M Buy
438,664
+12,741
+3% +$376K 0.01% 1878
2026
Q1 		$9.83M Buy
425,923
+143,971
+51% +$3.25M ﹤0.01% 2185
2025
Q4 		$5.67M Sell
281,952
-4,152
-1% -$86.4K ﹤0.01% 2874
2025
Q3 		$5.28M Buy
286,104
+109,935
+62% +$2.16M ﹤0.01% 3096
2025
Q2 		$3.84M Buy
176,169
+18,111
+11% +$376K ﹤0.01% 3257
2025
Q1 		$2.92M Buy
158,058
+105,513
+201% +$2.58M ﹤0.01% 3425
2024
Q4 		$1.4M Sell
52,545
-164,085
-76% -$4.71M ﹤0.01% 3917
2024
Q3 		$5.09M Buy
216,630
+204,527
+1,690% +$4.64M ﹤0.01% 2824
2024
Q2 		$225K Sell
12,103
-199,586
-94% -$3.56M ﹤0.01% 5077
2024
Q1 		$3.78M Buy
+211,689
New +$4.27M ﹤0.01% 3153

Other funds holding AVBP

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Israel Englander's AVBP Position: Q2 2026 in Review

Israel Englander increased its ArriVent BioPharma (AVBP) stake by 3% in Q2 2026, buying an estimated $376K and bringing the position to 438,664 shares worth $15.2M. The position accounts for 0.01% of the portfolio, ranked #1878.

Israel Englander first reported a position in AVBP in Q1 2024 and has held it in 10 quarters since. 157 funds tracked by Wall St. Rank hold AVBP as of Q2 2026.

  • Israel Englander held 438,664 shares of ArriVent BioPharma worth $15.2M as of Q2 2026.
  • Israel Englander bought 12,741 ArriVent BioPharma shares in Q2 2026, an estimated $376K.
  • ArriVent BioPharma made up 0.01% of Israel Englander's portfolio in Q2 2026, its #1878 holding.
  • Israel Englander first reported a position in ArriVent BioPharma in Q1 2024 and has held it in 10 quarters since.
  • 157 funds tracked by Wall St. Rank held ArriVent BioPharma as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.